155 related articles for article (PubMed ID: 16651699)
1. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets.
Yamakuni H; Nakayama H; Matsui S; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2006 May; 101(1):99-102. PubMed ID: 16651699
[TBL] [Abstract][Full Text] [Related]
2. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
Ozaki A; Sukamoto T
Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662
[TBL] [Abstract][Full Text] [Related]
3. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
Bhandari P; Andrews PL
Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
[TBL] [Abstract][Full Text] [Related]
5. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
King GL
J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets.
Minami M; Endo T; Tamakai H; Ogawa T; Hamaue N; Hirafuji M; Monma Y; Yoshioka M; Hagihara K
Eur J Pharmacol; 1997 Mar; 321(3):333-42. PubMed ID: 9085045
[TBL] [Abstract][Full Text] [Related]
8. Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret.
Fukunaka N; Sagae S; Kudo R; Endo T; Hirafuji M; Minami M
Gen Pharmacol; 1998 Nov; 31(5):775-81. PubMed ID: 9809477
[TBL] [Abstract][Full Text] [Related]
9. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX.
Fink-Jensen A; Judge ME; Hansen JB; Jacobsen P; Turski L; Olney J; Honoré T
Neurosci Lett; 1992 Mar; 137(2):173-7. PubMed ID: 1350077
[TBL] [Abstract][Full Text] [Related]
11. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
12. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
[TBL] [Abstract][Full Text] [Related]
13. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
14. Antiemetic effect of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin-induced acute and delayed emesis in ferrets.
Furukawa TY; Nakayama H; Imazumi K; Yamakuni H; Takeshita K; Matsuo M; Manda T; Uchida W
Biol Pharm Bull; 2014; 37(2):232-8. PubMed ID: 24492720
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
16. The antiemetic profile of zacopride.
Smith WL; Alphin RS; Jackson CB; Sancilio LF
J Pharm Pharmacol; 1989 Feb; 41(2):101-5. PubMed ID: 2568416
[TBL] [Abstract][Full Text] [Related]
17. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
Fernández AG; Puig J; Beleta J; Doménech T; Bou J; Berga P; Gristwood RW; Roberts DJ
Eur J Pharmacol; 1992 Nov; 222(2-3):257-64. PubMed ID: 1451737
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study.
Chua DT; Sham JS; Kwong DL; Kwok CC; Yue A; Foo YC; Chan R
Am J Clin Oncol; 2000 Apr; 23(2):185-91. PubMed ID: 10776982
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone.
Campos D; Pereira JR; Reinhardt RR; Carracedo C; Poli S; Vogel C; Martinez-Cedillo J; Erazo A; Wittreich J; Eriksson LO; Carides AD; Gertz BJ
J Clin Oncol; 2001 Mar; 19(6):1759-67. PubMed ID: 11251007
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
